AXDX

Accelerate Diagnostics

Delisted

AXDX was delisted on the 14th of May, 2025.

92 hedge funds and large institutions have $259M invested in Accelerate Diagnostics in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 15 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
-5
Holders Change %
-5.15%
% of All Funds
2.46%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
16
Increased
47
Reduced
15
Closed
19
Calls
$1.39M
Puts
$1.13M
Net Calls
+$258K
Net Calls Change
+$686K
Name Holding Trade Value Shares
Change
Shares
Change %
D.E. Shaw & Co
101
D.E. Shaw & Co
New York
-$247K -1,148 Closed
MIM
102
Monashee Investment Management
Massachusetts
-$246K -1,146 Closed
LCM
103
Laurion Capital Management
New York
-$245K -1,140 Closed
RG
104
Redmile Group
California
-$215K -1,000 Closed
OAM
105
Oxford Asset Management
United Kingdom
-$207K -964 Closed
AL
106
Airain Ltd
Guernsey
-$203K -946 Closed
BNP Paribas Financial Markets
107
BNP Paribas Financial Markets
France
-$114K -530 Closed
MCM
108
Mazama Capital Management
Oregon
-$26K -119 Closed
PA
109
Perceptive Advisors
New York
-$16K -75 Closed
TRCT
110
Tower Research Capital (TRC)
New York
-$6K -30 Closed
QI
111
QS Investors
New York
-$1K -1 Closed